VDAC1 and Alzheimer disease: Recently, VBIT-4 was developed as an inhibitor for VDAC-1, preventing the oligomerization of VDAC-1 and the formation of the heterologous oligomer between VDAC-1 and Aβ, making this inhibitor a potential drug candidate for the treatment of AD [64].